Portolan Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.47M | Buy |
1,980,409
+663,330
| +50% | +$2.5M | 0.47% | 69 |
|
|
2025
Q1 | $5.97M | Buy |
1,317,079
+568,050
| +76% | +$2.57M | 0.45% | 66 |
|
|
2024
Q4 | $5.3M | Buy |
749,029
+85,427
| +13% | +$604K | 0.36% | 86 |
|
|
2024
Q3 | $5.4M | Buy |
+663,602
| New | +$5.4M | 0.39% | 78 |
|
|
2022
Q4 | – | Sell |
-303,602
| Closed | -$2.95M | – | 143 |
|
|
2022
Q3 | $2.95M | Sell |
303,602
-253,625
| -46% | -$2.46M | 0.31% | 99 |
|
|
2022
Q2 | $8.07M | Buy |
557,227
+279,820
| +101% | +$4.05M | 0.81% | 46 |
|
|
2022
Q1 | $7.25M | Buy |
+277,407
| New | +$7.25M | 0.58% | 69 |
|